Infants, kids now have a Covid-19 therapy as FDA expands use of Eli Lilly drug


Eli Lilly’s authorized antibody drug for treating and preventing Covid-19 infection in adolescents and adults is now authorized for pediatric patients, including newborns. While tests are still assessing whether the drug works against omicron, early data suggest a Vir Biotechnology antibody can address the new variant but Regeneron Pharmaceuticals’ antibody drug might not.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.